Ubiquitin-fusion protein system: A powerful tool for ectopic protein expression in mammalian cells

BioTechniques

Volumn 46, Issue 1, 2009, Pages 21-28

  Matentzoglu, Konstantin ^a   Scheffner, Martin ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINE; GREEN FLUORESCENT PROTEINS; HUMANS; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; TRANSFECTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EUKARYOTA; MAMMALIA;

EID: 59149093045     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/000113023     Document Type: Article

References (18)

1. Duzgunes, N. and P.L. Felgner. 1993. Intracellular delivery of nucleic acids and transcription factors by cationic liposomes. Methods Enzymol. 221:303-306.
2. Felgner, P.L. and G. Ringold. 1989. Cationic liposome-mediated transfection. Nature 337:387-388.
3. Felgner, P.L., T.R. Gadek, M. Holm, R. Roman, H.W. Chan, M. Wenz, J.P. Northrop, G.M. Ringolg, and M. Danielsen. 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84:7413-7417.
4. Gossen, M. and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
5. Hillen, W. and C. Berens. 1994. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu. Rev. Microbiol. 48:345-369.
6. De La Luna, S. and J. Ortin. 1992. Pac gene as efficient dominant marker and reporter gene in mammalian cells. Methods Enzymol. 216:376-385.
7. McFarland, D.C. 2000. Preparation of pure cell cultures by cloning. Methods Cell Sci. 22:63-66.
8. Jackson, R.J., M.T. Howell, and A. Kaminski. 1990. The novel mechanism of initiation of picornavirus RNA translation. Trends Biochem. Sci. 12:477-483.
9. Jang, S.K., M.V. Davies, R.J. Kaufman, and E. Wimmer. 1989. Initiation of protein synthesis by internal entry of ribosomes into the 5′ nontranslated region of encephalomyocarditis virus RNA in vivo. J. Virol. 63:1651-1660.
10. Bachmair, A., D. Finley, and A. Varshavsky. 1986. In vivo half-life of a protein is a function of its amino-terminal residue. Science 234:179-186.
11. Varshavsky, A. 2005. Ubiquitin fusion technique and related methods. Methods Enzymol. 399:777-799.
12. Thrower, J.S., L. Hoffman, M. Rechsteiner, and C.M. Pickart. 2000. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19:94-102.
13. Pickart, C.M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:503-533.
14. Kuballa, P., K. Matentzoglu, and M. Scheffner. 2007. The role of the ubiquitin ligase E6-AP in human papillomavirus E6-mediated degradation of PDZ domain-containing proteins. J. Biol. Chem. 282:65-71.
15. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.
16. Scheffner, M. and N.J. Whitaker. 2003. Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin. Cancer Biol. 13:59-67.
17. Kishino, T., M. Lalande, and J. Wagstaff. 1997. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15:70-73.
18. Matsuura, T., J.S. Sutcliffe, P. Fang, R.J. Galjaard, Y.H. Jiang, C.S. Benton, J.M. Rommens, and A.L. Beaudet. 1997. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat. Genet. 15:74-77.